Alfredo Oliveros

1.2k total citations
51 papers, 932 citations indexed

About

Alfredo Oliveros is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Genetics. According to data from OpenAlex, Alfredo Oliveros has authored 51 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cellular and Molecular Neuroscience, 20 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Alfredo Oliveros's work include Neurotransmitter Receptor Influence on Behavior (11 papers), Neuroscience and Neuropharmacology Research (11 papers) and Receptor Mechanisms and Signaling (11 papers). Alfredo Oliveros is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (11 papers), Neuroscience and Neuropharmacology Research (11 papers) and Receptor Mechanisms and Signaling (11 papers). Alfredo Oliveros collaborates with scholars based in United States, Spain and Sweden. Alfredo Oliveros's co-authors include Doo‐Sup Choi, Mi‐Hyeon Jang, Elliott Richelson, Mona Boules, Katrina Williams, David J. Hinton, Daniel M. Lindberg, Amanda M. Shaw, Jennifer Ayers-Ringler and Christina L. Ruby and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Alfredo Oliveros

49 papers receiving 920 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alfredo Oliveros United States 19 364 353 133 131 116 51 932
Renata Leke Brazil 16 219 0.6× 349 1.0× 187 1.4× 97 0.7× 114 1.0× 22 861
Michael A. Ackley United States 13 287 0.8× 401 1.1× 89 0.7× 100 0.8× 152 1.3× 22 859
Jürgen Zschocke Germany 15 434 1.2× 236 0.7× 63 0.5× 170 1.3× 104 0.9× 19 904
Anti Kalda Estonia 19 560 1.5× 362 1.0× 44 0.3× 98 0.7× 92 0.8× 33 1.0k
Erik I. Charych United States 15 747 2.1× 492 1.4× 123 0.9× 283 2.2× 117 1.0× 18 1.3k
Galila Agam Israel 22 370 1.0× 270 0.8× 438 3.3× 162 1.2× 146 1.3× 49 1.2k
Kazuya Toriumi Japan 22 568 1.6× 254 0.7× 74 0.6× 173 1.3× 132 1.1× 57 1.1k
Analı́a Reinés Argentina 17 272 0.7× 244 0.7× 60 0.5× 108 0.8× 102 0.9× 29 775
Ariyuki Kagaya Japan 19 497 1.4× 549 1.6× 277 2.1× 252 1.9× 92 0.8× 64 1.2k

Countries citing papers authored by Alfredo Oliveros

Since Specialization
Citations

This map shows the geographic impact of Alfredo Oliveros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfredo Oliveros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfredo Oliveros more than expected).

Fields of papers citing papers by Alfredo Oliveros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfredo Oliveros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfredo Oliveros. The network helps show where Alfredo Oliveros may publish in the future.

Co-authorship network of co-authors of Alfredo Oliveros

This figure shows the co-authorship network connecting the top 25 collaborators of Alfredo Oliveros. A scholar is included among the top collaborators of Alfredo Oliveros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfredo Oliveros. Alfredo Oliveros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rashid, Mohammad Abdur, Alfredo Oliveros, Sang‐Hoon Kim, et al.. (2023). The selective cyclooxygenase-2 inhibitor NS398 ameliorates cisplatin-induced impairments in mitochondrial and cognitive function. Frontiers in Molecular Neuroscience. 16. 1295991–1295991. 3 indexed citations
2.
Oliveros, Alfredo, et al.. (2023). Chemobrain: An accelerated aging process linking adenosine A2A receptor signaling in cancer survivors. International review of neurobiology. 170. 267–305. 2 indexed citations
3.
Yoo, Ki Hyun, Mohammad Mamun Ur Rashid, Chang Hoon Cho, et al.. (2021). Nicotinamide Mononucleotide Prevents Cisplatin-Induced Cognitive Impairments. Cancer Research. 81(13). 3727–3737. 36 indexed citations
4.
Peyton, Lee, Alfredo Oliveros, Doo‐Sup Choi, & Mi‐Hyeon Jang. (2021). Hippocampal regenerative medicine: neurogenic implications for addiction and mental disorders. Experimental & Molecular Medicine. 53(3). 358–368. 20 indexed citations
5.
Yoo, Ki Hyun, et al.. (2020). Genetic Inhibition of sFRP3 Prevents Glial Reactivity in a Mouse Model of Accelerated Aging. International Neurourology Journal. 24(Suppl 2). 72–78. 6 indexed citations
6.
Cho, Chang Hoon, et al.. (2018). BubR1 Insufficiency Impairs Affective Behavior and Memory Function in Mice. International Neurourology Journal. 22(Suppl 3). S122–130. 6 indexed citations
7.
Oliveros, Alfredo, et al.. (2017). Adenosine A2A receptor and ERK-driven impulsivity potentiates hippocampal neuroblast proliferation. Translational Psychiatry. 7(4). e1095–e1095. 23 indexed citations
8.
Oliveros, Alfredo, Jonathon Sens, Markus K. Larsson, et al.. (2017). LPS-induced cortical kynurenic acid and neurogranin-NFAT signaling is associated with deficits in stimulus processing during Pavlovian conditioning. Journal of Neuroimmunology. 313. 1–9. 15 indexed citations
9.
Vadnie, Chelsea A., Jennifer Ayers-Ringler, Alfredo Oliveros, et al.. (2016). Antipsychotic-like effects of a neurotensin receptor type 1 agonist. Behavioural Brain Research. 305. 8–17. 23 indexed citations
10.
Larsson, Markus K., Maria Bhat, Sophie Imbeault, et al.. (2016). Repeated LPS Injection Induces Distinct Changes in the Kynurenine Pathway in Mice. Neurochemical Research. 41(9). 2243–2255. 27 indexed citations
11.
Vadnie, Chelsea A., David J. Hinton, Sun Choi, et al.. (2014). Activation of neurotensin receptor type 1 attenuates locomotor activity. Neuropharmacology. 85. 482–492. 29 indexed citations
12.
Nam, Hyung Wook, David J. Hinton, Na Young Kang, et al.. (2013). Adenosine Transporter ENT1 Regulates the Acquisition of Goal-Directed Behavior and Ethanol Drinking through A2AReceptor in the Dorsomedial Striatum. Journal of Neuroscience. 33(10). 4329–4338. 83 indexed citations
13.
Walss‐Bass, Consuelo, Alfredo Oliveros, Carolina Wiesner, et al.. (2013). New Model of Action for Mood Stabilizers: Phosphoproteome from Rat Pre-Frontal Cortex Synaptoneurosomal Preparations. PLoS ONE. 8(5). e52147–e52147. 29 indexed citations
14.
Winham, Stacey J., Alfredo B. Cuéllar‐Barboza, Alfredo Oliveros, et al.. (2013). Genome-wide association study of bipolar disorder accounting for effect of body mass index identifies a new risk allele in TCF7L2. Molecular Psychiatry. 19(9). 1010–1016. 77 indexed citations
15.
Boules, Mona, Zhimin Li, Katrina Williams, et al.. (2010). Hyperactivity of the dopaminergic system in NTS1 and NTS2 null mice. Neuropharmacology. 58(8). 1199–1205. 38 indexed citations
16.
Boules, Mona, et al.. (2009). Chronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing tolerance. Behavioural Brain Research. 207(1). 118–124. 13 indexed citations
17.
Boules, Mona, Tomofumi Miura, Alfredo Oliveros, et al.. (2009). NT79: A novel neurotensin analog with selective behavioral effects. Brain Research. 1308. 35–46. 44 indexed citations
18.
19.
Boules, Mona, Iver H. Iversen, Alfredo Oliveros, et al.. (2006). The neurotensin receptor agonist NT69L suppresses sucrose-reinforced operant behavior in the rat. Brain Research. 1127. 90–98. 12 indexed citations
20.
Oliveros, Alfredo, et al.. (1992). [Neuro-Behçet. Clinical study of 9 patients].. PubMed. 7(1). 10–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renata Leke Breakdown of academic impact, for papers by Michael A. Ackley Breakdown of academic impact, for papers by Jürgen Zschocke Breakdown of academic impact, for papers by Anti Kalda Breakdown of academic impact, for papers by Erik I. Charych Breakdown of academic impact, for papers by Galila Agam Breakdown of academic impact, for papers by Kazuya Toriumi Breakdown of academic impact, for papers by Analı́a Reinés Breakdown of academic impact, for papers by Ariyuki Kagaya
Rankless by CCL
2026